Heart Disease News and Research

Latest Heart Disease News and Research

FDA receives IDE application for CytoSorbents' CytoSorb cardiac surgery trial

FDA receives IDE application for CytoSorbents' CytoSorb cardiac surgery trial

Inovalon announces list of organizations supported through its charitable contributions during 2014

Inovalon announces list of organizations supported through its charitable contributions during 2014

FDA approves Hospira's Dyloject (diclofenac sodium) Injection for pain management

FDA approves Hospira's Dyloject (diclofenac sodium) Injection for pain management

STS, ESTS collaborate to help improve lung cancer care

STS, ESTS collaborate to help improve lung cancer care

Making New Year's resolution to quit smoking a reality

Making New Year's resolution to quit smoking a reality

InformedDNA and NIA Magellan to jointly offer evidence-based genetic benefits optimization program

InformedDNA and NIA Magellan to jointly offer evidence-based genetic benefits optimization program

Early use of heart failure drugs slows cardiac damage in boys, young men with DMD

Early use of heart failure drugs slows cardiac damage in boys, young men with DMD

Top notch endodontic care for patients with dental anxiety

Top notch endodontic care for patients with dental anxiety

Negative health effects of severe obesity

Negative health effects of severe obesity

Three common health problems tied to oral health

Three common health problems tied to oral health

Tianyin Pharmaceutical releases unaudited preliminary financial results for Q1 FY 2015

Tianyin Pharmaceutical releases unaudited preliminary financial results for Q1 FY 2015

FDA approves Novo Nordisk’s weight loss injection, Saxenda

FDA approves Novo Nordisk’s weight loss injection, Saxenda

Novastem uses Stemedica's stem cell products to treat patient in ischemic stroke study

Novastem uses Stemedica's stem cell products to treat patient in ischemic stroke study

Actavis receives complete response letter for nebivolol/valsartan FDC for treatment of hypertension

Actavis receives complete response letter for nebivolol/valsartan FDC for treatment of hypertension

Health Canada monitors recall of Jetfuel Superburn containing undeclared drug substances

Health Canada monitors recall of Jetfuel Superburn containing undeclared drug substances

Periods of extreme heat associated with increased hospitalization risk for older adults

Periods of extreme heat associated with increased hospitalization risk for older adults

Patent recognizes peptide that reduces tissue damage

Patent recognizes peptide that reduces tissue damage

Innovative software predicts sudden cardiac death in patients at risk of arrhythmia

Innovative software predicts sudden cardiac death in patients at risk of arrhythmia

Unauthorized weight loss product seized from two retail locations in southwest of Calgary

Unauthorized weight loss product seized from two retail locations in southwest of Calgary

CytoSorbents starts trading on The Nasdaq Capital Market

CytoSorbents starts trading on The Nasdaq Capital Market

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.